2/22, 11:52 AM (Source: TeleTrader)
more TeleTrader news

GSK, Sanofi to restart 2nd phase COVID vaccine trial

Sanofi S.A. and GlaxoSmithKline plc announced on Monday the two companies would initiate a new phase two COVID-19 vaccine study involving 720 volunteers aged 18 and over.

"We are confident that our vaccine candidate has strong potential and we are very encouraged by the latest preclinical data. This new phase 2 study will enable us to identify the final vaccine formulation for adults of all ages," Sanofi Executive Vice President Thomas Triomphe asserted.

If the second phase is successful, the last trial phase should begin in the second quarter of the year, with vaccine becoming available in the last trimester of 2021.

Breaking the News / ND